Stifel Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Stifel Financial's MRNA Position: Q3 2026 in Review
Stifel Financial reduced its Moderna (MRNA) stake by 80% in Q3 2026, selling an estimated $4.12M and leaving 9,755 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2118.
Stifel Financial first reported a position in MRNA in Q1 2020 and has held it in 27 quarters since. The position peaked at $25.7M in Q3 2021. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Stifel Financial held 9,755 shares of Moderna worth $1.88M as of Q3 2026.
- Stifel Financial sold 38,207 Moderna shares in Q3 2026, an estimated $4.12M.
- Moderna made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2118 holding.
- Stifel Financial first reported a position in Moderna in Q1 2020 and has held it in 27 quarters since.
- Stifel Financial's Moderna position peaked at $25.7M in Q3 2021.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.